Arch Therapeutics, Inc.(Other OTC/NBB : ARTH)
ARTH PreMarket: $ () as of AM
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Health Technology » Biotechnology
Arch Therapeutics, Inc. is a medical device company, which offers an innovative, elegant, and superior approach to the rapid cessation of bleeding and control of fluid leakage during surgery and trauma care. Its product candidate surgical hemostatic device is designed to achieve hemostasis in minimally invasive and open surgical procedures. Arch Therapeutics was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Wellesley, MA.